Heterocyclic compounds as anti-inflammatory agents

Current Bioactive Compounds

Volumn 3, Issue 2, 2007, Pages 91-108

  Sondhi, Sham M ^a   Dinodia, Monica ^a   Singh, Jaiveer ^a   Rani, Reshma ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

Author keywords

Anti inflammatory agents; Heterocyclic compounds; Non steroidal

Indexed keywords

ACETYLSALICYLIC ACID; ACRIDINE DERIVATIVE; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; GAULTHERIN; HETEROCYCLIC COMPOUND; IBUPROFEN; IMIDAZOLE DERIVATIVE; INDOMETACIN; ISOXAZOLE DERIVATIVE; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXADIAZOLE DERIVATIVE; OXAZOLE DERIVATIVE; PARACETAMOL; PYRAZINE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; RHUBARB EXTRACT; SALICYLIC ACID DERIVATIVE; THIAZOLE DERIVATIVE; TRAMADOL; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; DUODENUM ULCER; EDEMA; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; GAULTHERIA; HEART INFARCTION; HUMAN; INFLAMMATORY DISEASE; KIDNEY FAILURE; MALIGNANT NEOPLASTIC DISEASE; MONOTHERAPY; NEPHROTOXICITY; NONHUMAN; OSTEOARTHRITIS; PAIN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; REVIEW; RHEUMATOID ARTHRITIS; STOMACH ULCER; STROKE; STRUCTURE ACTIVITY RELATION;

EID: 34250329964     PISSN: 15734072     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340707780809554     Document Type: Review

References (148)

1. Singh, G. (1998) Recent consideration in non steroidal anti-inflammatory drug gastropathy. Am. J. Med., 105(1B), 31S-38S.
2. Klegeris, A., Mc Geer, P. L. (2005) Non steroidal anti-inflammatory drugs (NSAIDs) and other inflammatory agents in the treatment of neurodegenerative disease. Curr. Alzheimer Res., 2, 355-365.
3. Rainsford, K. D. (2005) The discovery, development and novel actions of nimesulide. 1-61 in Nimesulide-Actions & uses. Rainsford K.D. Ed. Publisher: Birkhaeuser Verlag, Basel, Switz. CODEN: 69HPRW Conference written in English.
4. Thomas, T., Nadackal, G. T., Thomas, K. (2003) Aspirin and diabetes: Inhibition of amylin aggregation by non steroidal anti-inflammatory drugs. Exp. Clin. Endocrinol. Diabetes, 111, 8-11.
5. Schattenkirchner, M. (1990) An updated safety profile of etodolac in several thousand patients. Eur. J. Rheumatol. Inflamm., 10, 56-65.
6. Friendel, H. A., Langtry, H. D., Buckley, M. M. (1993) Nabumetone: A reappraisal of its pharmacology and therapeutic use in rheumatic disease. Drugs, 45, 131-156.
7. Price-Forbes, A. N., Callaghan, R., Allen, M. E., Rowe, I. F. (2005) A regional audit of the use of COX-2 selective non steroidal anti-inflammatory drugs (NSAIDs) in rheumatology Clinics in the West Midlands, in relation to NICE guidelines. Rheumatology, 44, 921-924.
8. Galli, G., Panzeeta G. (2002) Do non steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects. J. Nephrol., 15, 480-488.
9. Mcevoy, G. K. (Ed). (1992) AHFS drug information. American Society of hospital pharmacists Inc. Bethesda. 1041-1126.
10. Mahmood, M., Zuberi, H. S., Ashtaq, M. K. (2001) Nitric oxide mediated effect of cyclo-oxygenase inhibitors. J. Pak. Med. Assoc., 51, 28-31.
11. Xie, W., Chipman, J. G., Robertson, D. L., Erikson, R. L., Simmons, D. L. (1991) Expression of a nitrogen responsive gene encoding prostaglandin synthase regulated by m- RNA splicing. Proc. Natl. Acad. Sci USA, 88, 2692-2696.
12. Feldman, M., Mc Mahan, A. T. (2000) Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional non steroidal anti-inflammatory drugs, with less gastrointestinal toxicity. Intern. Med., 132, 134-143.
13. Hawkey, C. J. (1999) COX-2 inhibitors. Lancet, 353, 307-314.
14. Bentolini, A., Ottani, A., Sandrini, M. (2002) Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Curr. Med. Chem., 9, 1033-1043.
15. Simon, L. S. (2001) Cox-2 inhibition. An advance or only pharmaceutical hype. Arthritis Care Res., 45, 209-215.
16. Oviedo J. A. Wolfe, M. (2001) Clinical potential of cyclooxy-genase-2 Inhibitors. BioDrugs, 15, 563-572.
17. Dogne, J. M., Supuran C. T., Pratico, D. (2005) Adverse cardiovascular effects of the coxibs. J. Med. Chem., 48, 2251-2257.
18. Chan F. K. L. Graham, D.Y. (2004) Prevention of non steroidal anti-inflammatory drug gastrointestinal complications-review and recommendations based on risk assessment. Aliment. Pharmacol. Ther., 19, 1051-1061.
19. Martel-Pelletier, J., Lajeunesse, D., Reboul, P., Pelletier, J. P. (2003) Therapeutic role of dual inhibitors of 5-LOX and COX selective and non selective non steroidal anti-inflammatory drugs. Ann. Rheum. Dis., 62, 501-509.
20. Zhang, B., He, X. L., Ding, Y., Du, G. H. (2006) Gaultherin, a natural salicylate derivative from Gaultheria Yunnanensis: Towards a better non-steroidal anti-inflammatory drugs. Eur J. pharmacol., 530, 166-171.
21. Jachak, S. M. (2006) Cycloxygenase inhibitory natural products: Current status. Curr. Med. Chem., 13, 659-678.
22. Ahmed, S., Anuntiyo, J., Malemud, C. J., Haqqi, T. M. (2005) Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review Evidence based complementary and alternative medicine. eCAM, 2, 301-308.
23. Ricci, M., Blasi, P., Giovagnoli, S., Rossi, C., Macchiarulo, G., Luca, G., Basta, G., Calafiore, R. (2005) Ketoprofen controlled release from composite microcapsules for cell encapsulation: effect on post- transplant acute inflammation. J. Control. Rel. Soc., 107, 395-407.
24. Hussien, A. T. F. (2005) A new pharmaceutical composition containing green lipped mussel extract and non steroidal anti-inflammatory drugs with high efficiency and minimum side effects. PCT Int. Appl. WO 2005 115076. Chem. Abst., 144, 27597.
25. Wang, Z. (2005) A Chinese medicinal composition for treating arthritis. Chinese Patent No CN 1628741 dated 22-6-2005.
26. Silverfield, J. C., Kamin, M., Wu, S. C., Rosenthal, N. (2002) Tramadol/ acetaminophen combination tablets for treatment of osteoarthritis flare pain: A multicenter, outpatent, randomized, double-blind, Placebo-controlled, parallel group, add-on study. Clin. Ther., 24, 282-297.
27. Lolli, M. L., Cena, C., Medana, C., Lozzarato, L., Morini, G., Coruzzi, G., Manarini, S., Frutteroo, R. Gasco, A. (2001) A New Class of Ibuprofen Derivatives with Reduced Gastrotoxicity. J. Med. Chem., 44, 3463-3468.
28. Ellis, J. L., Augustyniak, M. E., Cochran, E. D., Earl, R. A., Garvey, D. S., Gordon, L. J., Janero, D. R., Khanapure, S. P., L?s, L.G., Melim, T. L., Murty, M. G., Schwalb, D. J., Shumway, M. J., Selig, W. M., Trocha, A. M., Young, D. V., Zemtseva, I. S. (2005) NMI-1182, a gastro-protective cyclooxygenase inhibiting nitric oxide donor. Inflammopharmacology, 12, 521-534.
29. Fiorucci, S., Antonelli, E. (2005) Dual COX-inhibitors: The answer is NO? Curr. Top. Med. Chem., 5, 487-492.
30. Huguenin, S., Vacherot, F., Kheuang, L., Fleury, F. J. Jaurand, M. C., Bolla, M., Riffaud, J. P., Chopin, D. K. (2004) An?proliferative effect of nitrosulindac (NSX1102), a new nitric oxide- donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines. Mol. Cancer Ther., 3, 291-298.
31. Huguenin, S., Vacherot, F., Fleury, F. J., Riffaud, J. P., Chopin, D. K., Bolla, M., Jaurand, M. C. (2005) Evaluation of the antitumoral potential of different nitric oxide-donating-non steroidal anti-inflammatory drugs (NO-NSAIDs) on human urological tumor cell lines. Cancer Lett., 218, 163-170.
32. Bahekar, S. S., Shinde, D. B. (2004) Synthesis and anti-inflammatory activity of some [4, 6-(4-sustituted aryl)-2- thioxo-1,2,3,4-tetrahydro-pyrimidin -5-yl]-acetic acid derivatives. Bioorg. Med. Chem. Lett., 14, 1733-1736.
33. Paul S., Gupta, M., Gupta, R. (2000) Environmentally desirable synthesis without use of organic solvent: Synthesis of 6-aryl-2-[(carboxymethyl)- thio]-5-cyanopyrimidine-4(3H) one. Indian J. Heterocycl. Chem., 9, 313-314.
34. Hogenkamp, D. J., Nguyen, P., Shao, B. (2001) Preparation of aryl substituted pyridines, pyrimidines, pyrazines and triazines with anti convulsant and sodium channel blocking activity. PCT Int. Appl.WO 2001, 68, 612, Chem. Abst., 135, 257270.
35. Hall, I. H., Burnha, B. S., Elkins, A., Sood, A., Powell, W., Tomasz. J., Spielvogel, B. F. (1996) Boronated pyrimidines and purines as cytotoxic, hypolipidemic anti-inflammatory agents. Metal-Based Drugs, 3, 155-160.
36. Sondhi, S. M., Goyal, R. N., Lahoti, A. M., Singh, N., Shukla, R. Raghubir, R. (2005) Synthesis and biological evaluation of 2-thiopyrimidine derivatives. Bioorg. Med. Chem., 13, 3185-3195.
37. Molina, P., Aller, E., Lorenzo, A., Cremades, P. L., Rioja, I., Ubeda, A., Terencio, M. C., Alcaraz, M. J. (2001) Solid-Phase Synthesis and Inhibitory effects of Some Pyrido [1, 2-c]pyrimidine Derivatives on Leukocyte Functions and experimental Infalmmation. J. Med. Chem., 44, 1011-1014.
38. Bhagwat, S. S., Lee, C. H., Perner, R. J. and Gu, Y. C. (2001) Preparation of 6, 7-disubstituted-4- aminopyrido [2, 3-d]pyrimidines as adenosine kinase inhibitors. PCT Int. Appl. WO 2001,57,040, Chem. Abst., 135, 152822.
39. Vidal, A., Ferrandiz, M. L., Ubeba, A., Alarcon, A. A., Arques, J. S., Alcaraz, M. J. (2001) Effect of imidazo[1, 2-a]pyrimidine derivatives as leukocyte function. Inflamm. Res., 50, 317-320.
40. Hitoshi, A., Tsutomu, M., Hiroshi, I., Yosuke, Y., Seiji, A., Etsuo, O., Kaji, Y., Motoki, M., Koji, S., Ari, K., Satoshi, N., Katsuya, K., Takashi, S., Ichiro, M., Kimihisa, U., Shinya, F., Miho, I. (2003) Preparation of bicyclic pyrimidine derivatives as anti-inflammatory agents for treatment of allergic diseases. PCT Int. Appl., WO 2003, 10, 4230, Chem. Abst., 140, 42193.
41. Balkan, A., Goren, Z., Urgun, H., Calis, U., Cakar, A. N., Atila, P., Uzbay, T. (2002) Evaluation of the analgesic and anti- inflammatory activities of some thiazolo [4,5-d]pyrimidines. Arzneimittel- Forchung, 52, 467-467.
42. Bekhit, A. A., Fahmy, H.T.Y., Rostom, S. A. F., Baraka, A. M. (2003) Design and synthesis of some substituted 1H-pyrazolyl-thiazolo [4,5-d]pyrimidines as anti-inflammatory-antimicrobiol Agents. Eur. J. Med. Chem., 38, 27-36.
43. Shehata, I. A. (2003) Synthesis and preliminary evaluation of some new 1, 2, 4 triazolo [1, 5-c]pyrimidines as anti-inflammatory agents. J. Saudi Chem. Soc., 7, 207-212.
44. Sondhi, S. M., Singh, N., Johar, M., Kumar, A. (2005) Synthesis, anti-inflammatory and analgesic activities evaluation of some mono, bi and tricyclic pyrimidines derivatives. Bioorg. Med. Chem., 13, 61586166.
45. Sondhi, S. M., Rajvanshi, S., Johar, M., Bharti, N., Azam, A. Singh, A. K. (2002) Anti-inflammatory, analgesic and anti-amoebie activity evaluation of pyrimido[1, 6-a]benzimidazole derivatives synthesized by the reaction of ketoisothiocyanates with mono and diamines. Eur. J. Med. 37, 835-843.
46. Sondhi, S. M., Johar, M., Shukla, R., Raghubir, R., Bharu, N., Azam, A. (2001) Synthsis, Anti-inflammatory, Analgesic and Activity Evaluation of some Pyrimidobenzimidazole and imidazole Derivatives. Aust. J. Chem., 54, 461-467.
47. Sondhi, S. M., Johar, M., Rajvanshi, S.; Dastidar, S. G., Shukla, R., Raghubir, R. and Lown, J. W. (2001) Anticancer, Anti-inflammatiry and Analgesic Activity Evaluation of Heterocyclic Compounds Synthesized by the reaction of 4-Isothiocyanato-4-methyl pentane-2-one with substituted o-Phenylenediamines, o-Diaminopyrimidine and (un) substituted o-Diaminopyrimidines. Aust. J. Chem., 54, 69-74.
48. Kelly, T. A., Sorcek, R. J. (2001) Novel N-(pyridin-4-yl) nitrogen herocyclic compounds useful in the treatment of inflammatory disease. PCT Int. WO 01, 07, 048, Chem. Abst., 134, 131536.
49. Collin, X., Robert, J. M., Duflos, M., Wielgosz, G., LeBaut, G., Robin, D.C., Grimaud, N., Lang, F., Petit, J.Y. (2001) Synthesis of N-pyridinyl (methyl)-1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxamides and analogs and their anti-inflammatory activity in mice and rats. J. Pharm. Pharmacol., 53, 417-423.
50. Sondhi, S. M., Singh, N., Rajvanshi, S., Johar, M. (2005) Synthesis, hydrolysis over silica column, anticancer, anti-inflammatory and analgesic activity evaluation of some pyridine and pyrazine derivatives. Indian J. Chem., 44B, 387-399.
51. Weidner M. S. (2003) Pyridine carboxy derivatives and an aminosugar. U.S. Pat. Appl. Publ., US 2003,10,5034, Chem. Abst., 139, 12324.
52. Mochona, B., Wilson, T., Redda, K. (2003) Synthesis and anti-inflammatory activities of N-benzoylamino-1, 2, 3, 6-tetrahydropyridine analogs. Drugs Exp. Clin. Res., 29, 131-140.
53. Duflos, M., Nourrisson, M. R., Brelet, J., Courant, J., LeBaut, G., Grimaud, N., Petit, J. Y. (2001) N-Pyridinylindole-3-(alkyl) carbonamides and derivatives as potential systemic and topical inflammation inhibitors. Eur. J. Med. Chem., 36, 545-553.
54. de Souza, M. (2005) Synthesis and biological activity of natural thiazoles:An important class of heterocyclic compounds. J. Sulfur Chem., 26, 429-449.
55. Mohan, S., Attimarad, M. (2004) Synthesis of some 2-arylamino-4-phenylthiazole-5-acetic acids and esters as potent NSAIDs. Indian J. Heterocycl. Chem., 13, 339-342.
56. Papadopoulou, C., Geronikaki, A., Hadjipavlou, L. D. (2005) Syn-thesis and biological evaluation of new thiazolyl/ benzothiazolyl-amides, derivatives of 4-phenyl-piperazine. FARMACO, 60, 969-973.
57. Lynch, D. E., Hayer, R., Beddows, S., Howdle, J., Thake, C. D. (2006) Synthesis and activity of four (N, N-dimethylamino) benzamide non steroidal anti-inflammatory drugs based on thiazole and thiazoline. J. Heterocycl. Chem., 43, 191-197.
58. Venugopala, K. N., Jayashree, B. S., Attimarad, M. (2004) Synthesis and evaluation of some substituted 2-arylamino coumarinyl thiazoles as potential NSAIDs. Asian J. Chem., 16, 872-876.
59. Holla, B. S., Malini, K. V., Rao, B. S., Sarojini, B. K., Kumari, N. S. (2003) Synthesis of some new 2, 4-disubstituted thiazoles as possible antibacterial and anti-inflammatory agents. Eur. J. Med. Chem, 38, 313-318.
60. Tozkoparan, B., Aktay, G., Yesilada, E., Ertan, M. (2001) Synthesis of some thiazolo[3,2-b]-1,2,4-triazoles -5(6H)-ones and their novel Michael addition products with anti-inflammatory activities. Arzneimittel-Forschung, 51, 470-477.
61. Amir, M., Khan, M. S. Y., Zaman, M. S. (2004) Synthesis, characterization and biological activities of substituted oxadiazole, triazole, thiadiazole and 4-thiazolidinone derivatives. Indian J. Chem., 43B, 2189-2194.
62. Labanauskas, L., Brukstus, A., Udrenaite, E., Gaidelis, P., Bucinskaite, V. (2003) Synthesis and anti-inflammatory activity of 2-(1H-benzimidazol-2-ylthio)- and 2-[(1H-benzimidazole-2-ylmethyl) thio-1-(3,4-dialkoxyphenyl)-1-ethanones. Chemija, 14, 49-51.
63. Uenlue, S., Baytas, S. N., Kupeli, E., Yesilada, E. (2003) Studies on novel 7-acyl-5-chloro-2-oxo-3H-benzoxazole derivatives as potential analgesic and anti-inflammatory agents. Archiv der Pharmazie, 336, 310-321.
64. Brown, D. L., Graneto, M. J., Ludwig, C. L., Tally, J. J. (2001) Preparation of 2-Fluoro-benzenesulfonyl-heterocycles with COX-1 and COX-2 inhibiting activity for pharmaceutical use in the treatment of inflammation. PCT Int. Appl. WO 2001,081,332, Chem. Abst., 135, 344477.
65. Cheng, H., Li, J., Lundy, K. M., Minich, M. L., Sakya, S. M., Uchida, C. (2001) Preparation of heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents. PCT Int. Appl. WO 2001040216, Chem. Abst., 135, 33475.
66. 5-disubstituted-3-methyl-1H- pyrazolo [3,4-c]pyridazines. Bioorg. Med. Chem., 9, 715-718.
67. Sondhi, S. M. Singh, N., Lahoti, A. M., Bajaj, K., Kumar, A., Lozach, O. Meijer, L. (2005) Synthesis of acridinyl-thiozolino derivatives and their evaluation for anti-inflammatory, analgesic and kinase inhibition activities. Bioorg. Med. Chem., 13, 4291-4299.
68. Sondhi, S. M., Bhattacharjee, G., Jameel, R. K., Shukla, R., Raghubir, R., Lozach, O. Meijer, L. (2004) Anti-inflammatory, Analgesic and Kinase inhibition activities of some Acridine derivatives. Cent. Eur. J. Chem., 2, 1-15.
69. Sondhi, S. M., Johar, M., Singh, N., Shukla, R., Raghubir, R., Dastidar. S. G. (2002) Synthesis of Sulpha drug, acridine derivatives and their evaluation for anti-inflammatory, analgesic and anticancer activity. Indian J. Chem., 41B, 2659-2666.
70. Sondhi, S. M., Bhattacharjee, G., Jameel, R. K., Kumar, A., Bajaj, K. (2005) Kinetic studies on the reaction of various 9-chloroacridines with some arylsulfonyl hydrazides and anti-inflammatory and kinase inhibition activity of the products. Indian J. Chem., 44A, 232-240.
71. Marsik, P., Kokoska, L., Landa, P., Nepovim, A., Soudik, P., Vanek, T. (2005) In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1-and-2-catalyzed prostaglandin E2 biosyntheses. Planta Med., 71, 739-42.
72. Tubaro, E., Belogi, L., Mezzadri, C. M. (2000) The mechanism of action of amtolmetin guacyl, a new gastroprotective non steroidal anti-inflammatory drug. Eur. J. Pharmacol., 387, 233-244.
73. Geetha, T., Varalakshmi, P. (2001) Anti-inflammatory activity of lupeol and lupeol linoleate in rats. J. Ethnopharmacol., 76, 77-80.
74. Don, R. H., Ferro, V., Bytheway, I., Cochran, S., Fairweather, J. K., Hammond, E. T., Karoli, T., Li, C. P., Liu, L. (2005) Preparartion of glycosaminoglycan (GAG) mimetics as anti-angiogenic, anti-metastatic, and anti-inflammatory, anticoagulant, antithrombotic and antimicrobial agents. PCT Int. Appl. WO 2005, 061, 523, Chem. Abst., 143, 115755.
75. Barth, M., Bondoux, M., Dodey, P., Massardier, C., Thomas, D., Luccarini, J. M. (2004) Heterocyclic (piperazine- and piperidine- containing) benzenesulfonamide derivatives, method for their production, therapeutic compositions and use thereof for treatment of pain and inflammation. PCT Int. Appl. WO 2004, 087, 700, Chem. Abst., 141, 350198.
76. Sondhi, S. M., Dinodia, M., Kumar, A. (2006) Synthesis, anti-inflammatory and analgesic activity evaluation of some amidine and hydrazone derivatives. Bioorg. Med. Chem., 14, 4657-4663.
77. Sondhi, S. M., Singh, N., Kumar, A., Lozach, O., Meijer, L. (2006) Synthesis anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole / benzoxazole derivatives and some Schiff's bases. Bioorg. Med. Chem., 14, 3758-3765.
78. Monnier, Y., Zaric, J., Rüegg, C. (2005) Inhibition of Angiogenesis by Non-Steroidal Anti-Inflammatory Drugs: From the Bench to the Bedside and Back. Curr. Drug Targets-Inflam. Allerg, 4, 31-38.
79. Gasparini, G., Longo, R., Sarmiento, R. and Morabito, A. (2003) Inhibitiors of cyclooxygenase 2: a new class of anticancer agents? Lancet Oncol., 4, 605-15.
80. Ajith, T. A., Subin, J. P., Jacob, J., Sanjay, P. S., Babitha, N. V. (2005) Antimutagenic and anti-oxidant activities of the non-steriodal anti-inflammatory drug celecoxib. Clin. Exp. Pharmacol. Physiol., 32, 888-893.
81. Crew T. E., Elder, D. J., Paraskeva, C. (2000) A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate. Carcinogenesis, 21, 69-77.
82. Sciulli, M. G., Capone, M. L., Taccorelli, S., Patrignani, P. (2005) The Future of traditional nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and pain. Pharmacol. Rep., 15, 66-85.
83. Boehncke, S., Boehncke, W. H. (2005) Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs) Deutsche medizinische Wochenschrift (1946), 130, 2249-52.
84. Habeeb, A. G., Rao, P. N. P., Knaus, E. E. (2001) Design and synthesis of Celecoxib and Rofecoxib Analogues as Selective Cyclooxygenase-2(COX-2) inhibitors: Replacement of Sulfonamide and Methylsulfonyl Pharmacophores by an Azido Bioisostere. J. Med. Chem., 44, 3039-3042.
85. Del, Soldato, P., Santus, G. (2003) Nitroxy derivatives of non-steroidal anti-inflammatory compounds as selective inhibitors of cyclooxygenase-2 for the treatment of inflammation PCT Int. Appl. WO 2004, 00, 0300, Chem. Abst., 140, 73178.
86. Hill, M. R., Holland, S. J., Pearson, S. L., Yeates, K. T. (2004) Compositions containing pyrimidine derivatives as inhibitors of COX-2. PCT Int. Appl. WO 2004, 048, 344, Chem. Abst., 141, 38626.
87. Weingarten, G., Bravi, G. (2004) Preparation of pyrimidine derivatives as selective COX-2 inhibitors for treating pain, fever and inflammation. PCT Int. Appl. WO 2004, 018, 452, Chem. Abst., 140, 235741.
88. Agarwal, S. K., Tadiparthi, R. K., Aggarwal, P., Shivakumar, S. (2004) Preparation of pyrimidine derivatives for the treatment of inflammation and immunological diseases. PCT Int. Appl. WO 2004, 009, 560, Chem. Abst., 140, 146156.
89. Quintela, J. M., Peinador, C., Gonzalez, L., Devesa, I., Ferrandiz, M. L. Alcaraz, M. J. and Riguera, R. (2003) 6-Dimethylamino1H-Pyrazolo[3,4-d]pyrimidine Derivatives as New Inhibitors of Inflammatory Mediators in Intact Cells. Bioorg. Med. Chem., 11, 863-868.
90. Devesa, I., Alcaraz, M. J., Riguera, R., Ferrandiz, M. L. (2004) A new pyrazolo pyrimidine derivative inhibitor of cyclooxygenase-2 with anti-angiogenic activity. Eur. J. Pharmacol., 488, 225-230.
91. Ando, K., Kawamura, K., Kato, T., Minich, M. L., Lundy, K. M., Cheng, H. Li, J. Bronk, B. S., Sakya, S. M. (2001) Synthesis and use of heteroaryl phenyl pyrazoles as anti-inflammatory / analgesic agents. Eur. Pat. Appl. EP 1, 104, 759, Chem. Abst., 135, 19659.
92. Ando, K., Kawamura, K. (2001) Preparation of Sulfamoyl heteroaryl pyrazole compound as anti-inflammatory and analgesic agents. Eur. Pat. Appl. EP 1, 104, 760, Chem. Abst., 135, 33472.
93. Beswick, P., Modi, S., Pegg, N., Skidmore, J., Swarbrick, M. (2004) Preparation of [(methylsulfonyl)phenyl]pyridines as COX-2 inhibitors. PCT Int. Appl., WO 2004, 024, 691, Chem. Abst., 140, 287274.
94. Caturla, J. F., Warrellow, G. (2006) 2, 3′-Bipyridines useful as non steroidal anti-inflammatories, and their preparation, pharmaceutical compositions and use. Span, ES 2214130, Chem. Abst., 144, 108208.
95. Croitoru, M., Pintilie, L., Tanase, C., Caproiu, M. T., Draghici, C. (2005) New N-substituted pyrazolyl-benzenesulfonamide compounds as analogues of COX-2 selective inhibitors.II. N-Monosubstituted derivatives. Revista de Chimie (Bucharest, Romania), 56, 164-168.
96. Sui, Z., Guan, J., Ferro, M. P., McCoy, K., Wachter, M. P., Murray, W. V., Singer, M., Steber, M., Ritchie, D. M. and Argentieri, D. C. (2000) 1,3-Diarylcycloalkano pyrazoles and Diphenyl Hydrazides as Selective Inhibitors of Cyclooxygenase-2. Bioorg. Med. Chem. Lett., 10, 601-604.
97. Cheng, H., De Mello, K. M. L., Li, J., Sakya, S. M., Ando, K., Kawamura, K., Kato, T., Rafka, R. J., Jaynes, B. H., Ziegler, C. B., Stevens, R., Lund, L. A., Mann, D. W., Kilroy, C., Haven, M. L., Nimz, E. L., Dutra, J. K., Li, C., Minich, M. L., Kolosko, N. L., Petras, C., Silvia, A. M., Seibel, S. B. (2006) Synthesis and SAR of heteroaryl- phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors. Bioorg. Med. Chem. Lett., 16, 2076-2080.
98. Prasanna, S., Manivannan, E., Chaturvedi, S. C. (2005) QSAR analysis of conformationally restricted 1, 5-diaryl pyrazoles as selective COX-2 inhibitors: application of connection table representation of ligands. Bioorg. Med. Chem. lett., 15, 2097-2102.
99. Rapposelli, S., Lpucci, A.; Minutolo, F., Orlandini, E., Ortore, G., Pinza, M., Balsamo, A. (2004) Synthesis and COX-2 inhibitory properties of N-phenyl and N-benzyl substituted amides of 2-(4-methylsulfonylphenyl)-cyclopent-1-ene-1-carboxylic acid and of their pyrazole, thiophene and isoxazole analogs. IL FARMACO, 59, 25-31.
100. Rahim, M. A., Rao, P. N. P., Knaus, E. E. (2002) Synthesis of 4-alkyl-1,2-diphenyl-3,5-dioxopyrazolidines possessing arylmethylsulfonyl and sulfonamide pharmacophores for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. J. Heterocycl. Chem., 39, 1309-1314.
101. Carmen, A. R., Concepcion, G. G., Barreda, T., Carmen, M. (2001) Preparation of novel imidazole derivatives having anti-inflammatory activity. PCT Int. Appl. WO 2001, 070, 704, Chem. Abst., 135, 257245.
102. Gerd, D., Linda, H. (2002) Preparation of 2-mercapto-4, 5-diarylimidazoles as cyclooxygenase inhibitors for the treatment of diseases that are associated with a disturbed immune system. PCT Int. Appl. WO 2002, 076, 951, Chem. Abst., 137, 279188.
103. Carmen, A. R., Concepcion, G. G., Carmen, T. B.M. (2001) Novel heterocyclic compounds, namely imidazole sulfones and analogs with anti-inflammatory activity, their preparation, and their therapeutic use as cyclooxygenase-2 inhibitors. PCT Int. Appl. WO 2001, 083, 475, Chem. Abst., 135, 357924.
104. Satoshi, A., Toshiya, N., Nobukiyo, K., Katsuya, N., Hiroki, O., Ariyoshi, K., Norio, H. (2003) Preparation of triazole derivatives as cyclooxygenase inhibitors. PCT Int. Appl. WO 2003, 040, 110, Chem. Abst., 138, 368895.
105. Navidpour, L., Shafaroodi, H., Abdi, K., Amini, M., Ghahremani, M. H., Dehpour, A. R., Shafiee, A. (2006) Design, synthesis and biological evaluation of substituted 3- alkylthio-4,5-diaryl-4H-1,2,4-triazoles as selective COX-2 inhibitors. Bioorg. Med. Chem., 14, 2507-2517.
106. Dawood, K. M., Abdel-Gawad, H., Rageb, E. A., Ellithey, M. and Mohamed, H. A. (2006) Synthesis, anticonvulsant, and anti-inflammatory evaluation of some new benzotriazole and benzofuran-based heterocycles. Bioorg. Med. Chem., 14, 3672-3680.
107. Hashimoto, H., Imamura, K., Haruta, J. C., Wakitani, K. (2002) 4-(4-Cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as Selective Cyclooxygenase-2 inhibitors: Enhancement of the selectivity by Introduction of a Fluorine Atom and Identification of a Potent, Highly Selective, and orally Active COX-2 Inhibitor JTE-522. J. Med. Chem., 45, 1511-1517.
108. Habeeb, A. G., Rao, P. N. P., Knaus, E. E. (2001) Design and Synthesis of 4,5-Diphenyl-4-isoxazolines: Novel Inhibitors of Cyclooxygenase- 2 with Analgesic and Anti-inflammatory Activity. J. Med. Chem., 44, 2921-2927.
109. Faidallah, H. M., Basaif, S. A., Sharshira, E. M., A-Ba-Oun, A. E. K. (2002) Synthesis of N1-substituted, N3-[P-(3-ethoxycarbonyl-4,5-dihydronaptho[1,2-c]pyrazol-2-yl) benzenesulfonyl]urea and thiourea derivatives. Class of cyclooxygenase-2 inhibitors. Phosphorous Sulfur Silicon Relate. Elem., 177, 671-683.
110. Chen, Q. H., Rao, P. N. P., Knaus, E. E. (2005) Design, synthesis and biological evaluation of linear 1-(4-,3 or 2-methylsulfonylphenyl)-2-phenyl-acetylenes: A novel class of cyclooxygenase-2 inhibitors. Bioorg. Med. Chem., 13, 6425-6434.
111. Shen, F., Bai A. P., Guo, Z. R., Cheng, G. F. (2002), Inhibitory effect of 3, 4-diaryl-3-pyrrolin-2-one derivatives on cyclooxygenase 1 and 2 in murine peritoneal macrophages. Acta Pharmacol Sin., 23, 762-768.
112. Ouimet, N., Chan, C. C., Charleson, S., Claveau, D., Gordon, R., Guay, D., Li, C. S., Ouellet, M., Percival, D. M., Riendeau, D., Wong, E., Zamboni, R. Prasit, P. (1999) Substituted Heterocyclic Analogs as Selective COX-2 Inhibitors in the Flosulide Class. Bioorg. Med. Chem. Lett., 9, 151-156.
113. Joo, Y. H., Kim, J. K., Kang, S. H., Noh, M. S., Ha, J. Y., Choi, J. K., Lim, K. M., Lee, C. H., Chung, S. (2003) 2,3-Diarylben-zopyran derivatives as a novel class of selective cyclooxygenase-2 inhibitors. Bioorg. Med. Chem. Lett., 13, 413-417.
114. Singh, S. K., Saibaba, V., Ravikumar, V., Rudrawar, S. V., Daga, P., Rao, C. S., Akhila, V., Hegde, P., Rao, Y. K. (2004) Synthesis and biological evaluation of 2,3-diarylpyrazines and quinoxalines as selective COX-2 inhibitors. Bioorg. Med. Chem., 12, 1881-1893.
115. Willoughby D. A, Moore, A R, Colville-Nash P. R. (2000) COX-1, COX-2, and COX-3 and future treatment of chronic inflammatory disease. Lancet, 355, (9204), 646-648.
116. Chandrasckharan, N. V., Dai, H., Ross, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., Simmons, D. L. (2002) COX-3 a cyclooxygenase-1 varient inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning structure and empression. Proc. Natl. Acad. Sci. USA, 99, 13926-13931.
117. Warner, T. D. and Mitchell, J. A. (2002) Cyclooxygenase-3 (COX-3): filling in the gaps towards a COX continuum? Proc. Natl. Acad. Sci. USA, 99, 13371-13373.
118. Botting, R. (2003) COX-1 and COX-3 inhibitors. Thromb. Res., 110, 269-272.
119. Botting, R. M. (2006) Cyclooxygenase: past, present and future. A tribute to Jane R. Vane (1927-2004). J. Therm. Biol., 31, 208-219.
120. Warner, T. D., Vojnovic, I., Giuliano, F., Jimenez, R., Bishop, B. D., Mitchell, J. A. (2004) Cyclooxygenase 1,2 and 3 and the production of prostaglandin I2: Investigating the activities of acetaminophen and cycloxygenase-2 selective inhibitors in rat tissues. J. Pharmacol. Exp. Ther., 310, 642-647.
121. Hersh, E. V., Lally, E. T., Moore, P. A. (2005) Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray? Curr. Med. Res. Opin., 21, 1217-1226.
122. Singh, V. P., Patil, C. S., Kulkarni, S. K. (2004) Effect of 5- lipoxygenase inhibition on events associated with inflammatory bowel disease in rats. Indian J. Exp. Biol., 42, 667-673.
123. Larza, E. M. G., Manez, S., Recio, M. C., Giner, R. M., Prieto, J. M., Nicolas, M. C., Rios, J. L. (2001) Oleononic acid, a 3-oxotriterpenre from pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity. Eur. J. Pharmacol., 428, 137-143.
124. Lewis, T. A., Bayless, L., Dipesa, A. J., Eckman, J. B., Gillard, M., Libertine, L., Scannell, R. T., Wipij, D. M., Young, M. A. (2005) 5-Lipoxygenase inhibition by N-hydroxycarbamates in dual function compounds. Bioorg. Med. Chem. Lett., 15, 1083-1085.
125. Martel-Pelletier J., Lajeunesse, D., Reboul, P., Pelletier J-P. (2003) Theurapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non steroidal anti inflammatory drugs. Ann. Rheum. Dis., 62, 501-509.
126. Ulbrich, H., Fiebich, B., Dannhardt, G. (2002) Cyclooxygenase-1/2 (COX-1/ COX-2) and 5-lipoxygenase (5-LOX) inhibitors of the 6, 7 diaryl- 2, 3-1H-dihydropyrrolizine type. Eur. J. Med. Chem., 37, 953-959.
127. Rao, P. N. P., Chen, Q. H., Knaus. E. E. (2005) Synthesis and biological evaluation of 1, 3-diphenylprop-2-yn-1-ones as dual inhibitors of cyclooxygenases and lipooxygenases. Bioorg. Med. Chem. Lett., 15, 4842-4845.
128. Rao, P. N. P., Chen, Q. H., Knaus. E. E. (2006) Synthesis and structure-Activity Relationship Studies of 1, 3-diarylprop-2-yn-1-ones: Dual inhibitors of Cyclooxygenases and lipooxygenases. J. Med. Chem., 49, 1668-1683.
129. Kawano, K., Taniguchi, M., Igarashi, A., Yamada, M., Naito, K., Toyota, Y. (2004) Preparation of pyrazole-4-alkanoic acid derivatives as cyclooxygenase and 5-lipooxygenase inhibitors. PCT Int Appl., WO 2004, 037, 793, Chem. Abst., 140, 391278.
130. Talley, J. J., Sikorski, J. A., Granato, M. L, Carter, J. S., Norman, B. H., Devadas, B. (2002) Preparation of heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipooxygenase inhibitors.U.S. Pat. Appl. Publ., US 2002, 058, 810, Chem. Abst., 136, 369710.
131. Gay, R. E., Neidhart, M., Pataky, F., Tries, S., Laufer, S., Steffen, G. (2001) Dual inhibition of 5- lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction is adjuvant arthritis. J. Rheumatol., 28, 2060-2065.
132. Smolka, A. J., Goldenring, J. R., Gupta, S., Hammond, C. E. (2004) Inhibition of gastric H, K-ATPase activity and gastric epithelial cell IL-8 secretion by the pyrrolizine derivative ML3000. Chem. Abst., 141, 25358.
133. Bias, P., Buchner, A., Klesser, B., Laufer, S. (2004) The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial. Am. J. Gastroenterol., 99, 611-618.
134. Rotondo, S., Krauze, B. K., Manarini, S., Evangelista, V., Cerletti, C. (2004) Licofelone an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cycloxygenase-1-depandent platelet activation. Eur. J. Pharmacol., 488, 79-83.
135. Lee, S. H., Son, M. J., Ju, H. K., Lin, C. X., Moon, T. C., Choi, H. G., Son, J. K., Chang, H. W. (2004) Dual inhibition of cyclooxygenase-2 and 5-lipoxygenase by deoxypodophyllotoxin in mouse bone marrow-derived mast cells. Biol. Pharm. Bull., 27, 786-788.
136. Pommery, N., Taverne, T., Telliez, A., Goossens, L., Charlier, C., Pommery, J., Goossens, J. F., Houssin, R., Durant, F., Henichart, J. P. (2004) New COX-2/5-LOX inhibitors: Apoptosis-Inducing agents Potentially Useful in Prostate Cancer Chemo-therapy. J. Med. Chem., 47, 6195-6206.
137. Sunderman, B., Maul, C., Hennies, H. H., Schneider, J. (2002) Imidazo [1, 2-a]pyridine-imidazo[1, 2-a]pyrimidine and imidazo[1, 2-a]pyrazine-3-yl-amine derivatives for nitric oxide synthase-inhibiting pharmaceuticals. PCT Int. Appl. WO 2002, 030, 428, Chem. Abst., 136, 319426.
138. Xu, Y. G., Luo, S., Hua, W. Y., Zhu, D. Y. (2004) Synthesis and biological activity of 5-alkyl (or arylalkyl)-1-alkyl (or acyl)-3-[4-(5-methoxy (or chloro) benzimidazole-2-mercapto)phenyl] isothiourea. Youji Huaxue, 24, 210-215. Chem. Abst., 141, 23473
139. Bilodeau, M. J., Manley, P. J., Hartman, G. D. (2003) Preparation of fused heterocycle substituted aminothiazolecarbonitrile as tyrosine kinase inhibitors. PCT Int. Appl. WO 2003, 009, 852, Chem. Abst., 138, 137303.
140. Fraley, M. E., Peckhan, J. P., Arrington, K. L., Hoffman, W.F., Hartmen, G. D. (2003) Preparation of 4-(pyrazolyl)-2-pyrimidine-amines as tyrosine kinase inhibitors. PCT Int Appl. WO 2003, 011, 837, Chem. Abst., 138, 15354118.
141. Eatherton, A. J., Giblin, G. M. P., Mitchell, W. L., Naylor, A., Rawlings, D. A., Wall, I. D. (2005) Preparation of 2-(phenyl-amino)-pyrimidin-5-amides as cannabinoid 2 receptors mediators for the treatment of immune or inflammatory disorders. PCF Int. Appl. WO 2005, 075, 440, Chem. Abst., 143, 211924.
142. 2a receptors binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation related diseases. PCT Int. Appl. WO 2003, 088, 963, Chem. Abst., 139, 350637.
143. Ushiyama, S., Kimura, T. (2002) Preparation of hexahydro-indolidinyl) pyrrole, thiophene, pyrazole and imidazole derivatives as cytokine production inhibitors and their novel medicinal use in combination with nonsteroidal anti-inflammatory agents. PCT Int. Appl. WO 2002, 080, 974, Chem. Abst., 137, 310916.
144. Cirillo, P. F., Hickey, E. R., Regan, J. R. (2000) Methods for preparation of aromatic heterocyclic sunbstituted urea and thiourea derivatives as non steroidal and inflammatory agents. PCT Int. Appl. WO 2000 055152, Chem. Abst., 133, 252173.
145. Love, C. J., Van, W., Jean, P. F., De, B., Marc, j., Moses, R. C., Goncharenko, M., Cooymans, L. P., Vandermaesen, N., Diels, G. S. T., Sibley, A. W., Noula, C. (2003) Preparation of pyrimidinyl-thiazoles as antiinflammatories. PCT Int. Appl. WO 2003, 015, 776, Chem. Abst., 138, 187786.
146. Tsuruoka, H., Kanno, Y., Tatsuta, T. (2003) Preparation of pyrimidine derivatives as mixed lymphocyte reaction (MLR) inhibitors. PCT Int. Appl. WO 2003, 09, 223, Chem. Abst., 139, 364950.
147. Fu, Z., Johnson, M. G., Li, A. R., Marcus, A. P., Medina, J. C., Bergeron, P., Chen, X., Deignan, J., Du, X., Duquette, J. A., Gustin, D., Mihalic, J. T. (2006) Preparation of imidazole derivatives as CXCR3 inhibitors for treatment of inflammation and immune diseases. PCT Int. Appl. WO 2006, 004, 924, Chem. Abst., 144, 128974.
148. Ayscough, A. P., Davies, S. J., Pain, G., Gillon, J. Y. (2003) Preparation of oxadiazoles and thiadiazoles and their use as metalloproteinase inhibitors. PCT Int. Appl., WO 2003, 070, 711, Chem. Abst., 139, 21114470.